Clinical Report: Epidemiology, Genetic Features, and Prognosis of Pediatric Cardiomyopathy
Background
Pediatric cardiomyopathy is a rare but serious condition that can lead to heart failure and unexpected mortality in children. Understanding its epidemiology and genetic underpinnings is crucial.
Data Highlights
No numerical data available in the provided material.
Key Findings
Pediatric cardiomyopathy has an estimated incidence of approximately 1 in 100,000 children.
The major phenotypes include Dilated Cardiomyopathy (DCM) and Hypertrophic Cardiomyopathy (HCM).
DCM is the leading cause of pediatric heart transplantation.
Genetic testing is essential for identifying pathogenic variants in affected children.
Clinical outcomes include the need for implantable devices, heart transplantation, or death.
Clinical Implications
Genetic testing is important in pediatric cardiomyopathy to guide management and treatment decisions.
Conclusion
This study highlights the importance of a comprehensive approach to pediatric cardiomyopathy.
by Scott Kendall, Shannon Scott, Peter McClung, Joy McCance, Nawab Ali, Gillian Rea, William Wright, Jane Murray, Alison Muir, Martin Dempster, Terrence Prendiville, Pascal McKeown, Frank Casey
